The use of genetic information in the insurance sector - a German perspective

El presente trabajo ofrece una introducción al marco normativo alemán relativo a la utilización de la información genética en el sector de los seguros. Se examinan los principales contenidos y los temas más controvertidos de la normativa en cuestión. El objetivo de esta norma es garantizar de dignidad humana, respetando el derecho a la autodeterminación informativa en relación con los datos genéticos, incluyendo el derecho del individuo a no saber acerca de sus características genéticas, habiendo una serie de cuestiones abiertas que han de ser abordadas. En este sentido, se examina la influencia de la prohibición de solicitar pruebas genéticas y de utilizar los resultados de dichas pruebas por la aseguradora. En examen lleva a algunos resultados explícitos, como la suposición de que, además de la prohibición del uso de las pruebas genéticas, el hecho de que las preguntas sobre el historial médico de la familia sean inadmisibles. Los autores abordan la definición de las pruebas genéticas y la cuestión de en qué medida los resultados de las pruebas genéticas de diagnóstico todavía puede hacerse uso de en el contexto de la obligación de la persona asegurada para mostrar condiciones y enfermedades preexistentes, en el momento de la celebración del contrato (...) (AU)

The following paper offers an introduction to the legal framework concerning the use of genetic information in the insurance sector in Germany. The main contents and the controversial issues of the key regulation are examined. The aim of this rule being to secure human dignity by respecting the rights to informational self-determination regarding genetic data, including the individual’s right not to know about their genetic characteristics, there are a number of open issues which are being addressed. For instance, the influence of the prohibition to ask for genetic testing and to use the results of any such testing by the insurer is examined. This examination leads to some explicit results, such as the assumption that in addition to the ban on the use of genetic testing no questions about family medical history are admissible. The authors embark on the definition of genetic testing and the question to what extent the results of diagnostic genetic testing may still be made use of in the context of the insured person´s obligation to display preexisting conditions and diseases when the contract is concluded (...) (AU)

The use of genetic information in the insurance sector--a German perspective.

The following paper offers an introduction to the legal framework concerning the use of genetic information in the insurance sector in Germany. The main contents and the controversial issues of the key regulation are examined. The aim of this rule being to secure human dignity by respecting the right to informational self-determination regarding genetic data, including the individual's right not to know about their genetic characteristics, there are a number of open issues which are being addressed. For instance, the influence of the prohibition to ask for genetic testing and to use the results of any such testing by the insurer is examined. This examination leads to some explicit results, such as the assumption that in addition to the ban on the use of genetic testing no questions about family medical history are admissible. The authors embark on the definition of genetic testing and the question to what extent the results of diagnostic genetic testing may still be made use of in the context of the insured person's obligation to display pre-existing conditions and diseases when the contract is concluded. In this respect distinctions between diagnostic and predictive genetic testing as well as between disease and disposition are drawn. Furthermore, the exceptions from the prohibition to use results of genetic testing are examined, and the scope of the prohibition of acceptance of results of genetic testing even if performed at the instigation of the insured is explored. Finally the consequences, encompassing criminal liability and private law ramifications, of the violation of the prohibition are presented. In this context, a narrow understanding of the aggravated criminal offence of using results of genetic testing with the intent to personal enrichment or in return for payments is developed. Finally the effects on the validity of the insurance contract and the question whether the insurer may be forced to conclude a contract are examined.